The Right Trials, Patients, and Places for Meaningful Oncology Research

Innovative research requires an ingenious mediation of patient and program needs. Worldwide excels in the essentials while taking a vanguard approach to the latest in preclinical science and study design.


Many of our oncology team members have spent time conducting research or clinical care themselves, giving them an edge in overcoming the operational and patient-centered challenges that often plague trials conducted in this space. From preclinical and dose escalation expertise to regulatory approval, we are just the right size to offer accessible, nimble attention and a bevy of the industry’s top talent. That’s why Worldwide is rated a top performer for staff, delivery, budget and loyalty across phase I-III CRO services by Industry Standard Research.



Clare has held responsibilities at all levels of drug development including data manager, clinical research associate, global project management lead, and more. Clare’s experience is invaluable in guiding and supporting operational teams in achieving project success. From project planning, execution, oversight, to patient recruitment, team mentoring, and sponsor engagement, Clare is well-versed in mitigating risks and creating a culture of effective communication among stakeholders and team members for optimal results.

Expertise You Can Rely On 

We’ve cultivated a tenured, talented team of experts to craft unique, resourceful solutions for each and every project. Forge a partnership that matters and let Worldwide Clinical Trials Oncology introduce you to the research experience you deserve.

Oncology Experience

  • Common Cancers
  • Advanced Solid Tumors
  • Breast Cancer
  • Cervical Cancer
  • Chemo Induced Anorexia or Cachexia
  • Colorectal Cancer
  • Endometrial Cancer
  • Melanoma
  • Myelodysplastic Syndrome
  • Non-Hodgkin Lymphoma
  • Non-Small Cell Lung Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Stomach Cancer
  • Tenosynovial Giant Cell Tumor
  • Rare Cancers
  • Acute Myeloid Leukemia (AML)
  • B-Cell Non-Hodgkin Lymphoma
  • Cutaneous T-Cell Lymphoma
  • Gastrointestinal Stromal Tumor (GIST)
  • Glioblastoma Multiforme (GBM)
  • Hepatocellular Carcinoma
  • Idiopathic Thrombocytopenic Purpura
  • Triple-Negative Breast Cancer
  • Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF)

Our Dedicated Team